<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01471275</url>
  </required_header>
  <id_info>
    <org_study_id>368</org_study_id>
    <nct_id>NCT01471275</nct_id>
  </id_info>
  <brief_title>Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia</brief_title>
  <official_title>The Study of TCM in Prevention and Promote of Community-based Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With metformin for the control, evaluate the safety and efficacy of Jiangtangtiaozhi
      decoction in treatment of obesity with type 2 diabetes, dyslipidemia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Waist circumference, body mass index, triglycerides, glycosylated hemoglobin, blood glucose
      were evaluated; liver function, kidney function, blood, urine, stool, adverse event
      recording, evaluation of low blood sugar event log security.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycosylated hemoglobin</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Waistline</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole blood cell analysis</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinalysis</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events recorded</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Type 2 Diabetes Mellitus ;Obesity,High Triglycerides；TCM</condition>
  <arm_group>
    <arm_group_label>Jiangtangtiaozhi decoction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>metformin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>250 mg or 500mg three times a day</description>
    <arm_group_label>metformin</arm_group_label>
    <other_name>Metformin enteric-coated tablets.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Jiangtangtiaozhi decoction</intervention_name>
    <description>15 grams each time, twice a day, with boiled water</description>
    <arm_group_label>Jiangtangtiaozhi decoction</arm_group_label>
    <other_name>a decoction make of 8 herbs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. signed informed consent;

          2. waistline male ≥ 90cm, female ≥ 80cm;

          3. According to the 1999 WHO standards, meet diagnostic criteria for type 2 diabetes
             onset and untreated patients, after a screening period (diet + exercise therapy 4
             weeks) after the fasting plasma glucose ≥ 7.0mmol • L-1, but fasting blood glucose
             &lt;13.9mmol • L-1, or 2h postprandial blood glucose ≥ 11.1mmol • L-1; and glycated
             hemoglobin ≥ 7.0%;

          4. After a screening period (diet + exercise therapy 4 weeks) after the triglyceride (TG)
             ≥ 1.7mmol / L, and TG &lt;5.65mmol / L;

          5. TCM for the heat of the gastrointestinal;

          6. Age 30-65 years old.

        Exclusion Criteria:

          1. Patients has been used insulin therapy; previously had a continuous period of 3 months
             or longer treatment of diabetes(including other Chinese and Western medicine, physical
             therapy, psychological therapy and health food, etc.) ; enrolled within 1 month before
             the use of blood glucose and lipids drug treatment;

          2. Patients with diabetic complications; or a serious heart, lung, liver, kidney, brain
             and other serious complications or associated with other primary diseases;

          3. Patients with uncontrolled blood pressure control, the systolic blood pressure ≥
             160mmHg or (and) diastolic blood pressure ≥ 100mmHg persons;

          4. Patients have diabetic ketoacidosis in the last month, diabetic ketoacidosis and
             severe infections;

          5. Patients with mental illness;

          6. Pregnancy, pregnancy or breast-feeding women to prepare;

          7. Patients with Chinese medicine allergies; and allergy;

          8. Patients with had participated in this study within 1 month have participated or are
             participating in other clinical studies;

          9. In the past five years, patients with alcohol and / or psychoactive substances, drug
             abuse and dependence;

         10. According to the researchers to determine, with the possibility of lower income group
             or the other into a complex set of diseases or conditions, such as work environment,
             frequent changes in unstable living environment, the situation could easily lead to
             lost;

         11. Patients taking the dose and type of antihypertensive drugs can not remain stable;

         12. Patients taking drugs that affect the quality of the body or health food.

         13. Patients with liver, impaired renal function (ALT, AST greater than 2 times the upper
             limit of normal; serum creatinine greater than the upper limit of normal);

         14. Patients are known to lower blood sugar for those who are asymptomatic.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaolin Tong</last_name>
    <role>Study Chair</role>
    <affiliation>China academy of Chinese medical science</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lian Fengmei, doctor</last_name>
    <email>lfm565@sohu.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiang Zhou, doctor</last_name>
    <email>15101016416@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guang'anmen Hospital of China Academy ofChinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhou Qiang, doctor</last_name>
      <phone>15101016416</phone>
      <email>15101016416@126.com</email>
    </contact>
    <investigator>
      <last_name>Tong Xianlin, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lian Fengmei, professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhou Qiang, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baoding Hospital of TCM</name>
      <address>
        <city>Baoding</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Liping</last_name>
      <email>lilipingm@163.com</email>
    </contact>
    <investigator>
      <last_name>Li Liping, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Changchun University of TCM</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piao Chunli, professor</last_name>
      <email>piaochunli981027@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Piao Chunli, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wang Yanyan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qinghai Provence Hospital of TCM</name>
      <address>
        <city>Xining</city>
        <state>Qinghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pu Weirong</last_name>
      <email>puweirong123@163.com</email>
    </contact>
    <investigator>
      <last_name>Ba Zhuoma, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pu Weirong</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Dagang Hospital</name>
      <address>
        <city>Dagang</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Chuan</last_name>
      <email>58023442@qq.com</email>
    </contact>
    <investigator>
      <last_name>Guo Hailong</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jin Chuan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin University of Traditional Chinese Medicine, First Affiliated Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wu Shentao, professor</last_name>
      <phone>13752262891</phone>
      <email>wushentao@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Wu Shentao, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wang Bin, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yichang City Yiling Hospital</name>
      <address>
        <city>Yichang</city>
        <state>Yichang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Xingzhong</last_name>
      <email>clcy0401@163.com</email>
    </contact>
    <investigator>
      <last_name>Yang Xingzhong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hangzhou Hospital of TCM</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Yuzhi, professor</last_name>
      <email>hyzhcy@yahoo.cn</email>
    </contact>
    <investigator>
      <last_name>Hong Yuzhi, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Yan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2011</study_first_submitted>
  <study_first_submitted_qc>November 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2011</study_first_posted>
  <last_update_submitted>December 5, 2011</last_update_submitted>
  <last_update_submitted_qc>December 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</investigator_affiliation>
    <investigator_full_name>Fengmei Lian</investigator_full_name>
    <investigator_title>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</investigator_title>
  </responsible_party>
  <keyword>type 2 diabetes</keyword>
  <keyword>obesity</keyword>
  <keyword>hypertriglyceridemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hypertriglyceridemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

